Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects.
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients.
Fingolimod modulates microglial activation to augment markers of remyelination.
SIRT1 deacetylates RORγt and enhances Th17 cell generation.
The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.
Demyelination affects temporal aspects of perception: An optic neuritis study.
White matter astrocytes in health and disease.
Identification of the LDL Receptor-Related Protein-1 Interactome in Central Nervous System myelin suggests a role in the clearance of necrotic cell debris.
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.
Amiloride HCl
Biogen Idec announces positive top-line results from Phase 3 study of peginterferon beta-1a in multiple sclerosis
Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis.
Shorter washout reduces MS relapse switching off natalizumab
Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis.
2nd Annual Congress on Neurology and Epidemiology
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
Centocor briefing document for Ustekinumab, submitted to FDA
Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study.
Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate
Health Canada Approves PLEGRIDY™ (peginterferon beta-1a) for Adults with Relapsing Remitting Multiple Sclerosis
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
Control of experimental autoimmune uveoretinitis by low dose T cell vaccination.
Fingolimod phosphate promotes the neuroprotective effects of microglia.
Laquinimod

Pages